Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)PD-L1 Expression in Lung Cancer
Phase 2
Recruiting
- Conditions
- Non-Small Cell Lung Cancer
- First Posted Date
- 2021-08-05
- Last Posted Date
- 2023-03-22
- Lead Sponsor
- NanoMab Technology (UK) Limited
- Target Recruit Count
- 15
- Registration Number
- NCT04992715
- Locations
- 🇬🇧
Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
News
No news found